HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antibiotic prophylaxis for bacterial meningitis: overuse and uncertain efficacy.

AbstractBACKGROUND: There is little evidence supporting the efficacy of prophylactic antibiotics in preventing secondary cases of bacterial meningitis, and recent guidance extended the use of prophylactic antibiotics amongst children who attend pre-school groups. METHODS: We examined the volume of rifampicin prescribed, and that recommended to contacts of cases of meningococcal and Hib meningitis in Somerset over a three-year period using case note records of the Consultant for Communicable Disease Control (CCDC) and PACT data. RESULTS: There was evidence of excessive prescribing over and above that recommended by the CCDC. CONCLUSIONS: Excessive prescribing increases the chance of serious drug side effects and the development of antibiotic resistance. It is suggested that both meningitis contacts and information about early symptoms of meningitis, as well as an explanation of the rationale behind the prescribing of antibiotic prophylaxis to contacts. This may reduce the likelihood of unnecessary prescribing and subsequent complications.
AuthorsN Pearson, D J Gunnell, C Dunn, T Beswick, A Hill, B Ley (Affiliation: Somerset Health Authority.)
JournalJournal of public health medicine (J Public Health Med) Vol. 17 Issue 4 Pg. 455-8 (Dec 1995) ISSN: 0957-4832 [Print] ENGLAND
PMID8639346 (Publication Type: Journal Article)
Chemical References
  • Rifampin
Topics
  • Adult
  • Antibiotic Prophylaxis
  • Child
  • Child Day Care Centers
  • Child, Preschool
  • Contact Tracing
  • Cross Infection (prevention & control, transmission)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Utilization
  • England
  • Family Practice
  • Female
  • Health Services Misuse
  • Humans
  • Infant
  • Male
  • Meningitis, Bacterial (prevention & control, transmission)
  • Meningitis, Haemophilus (prevention & control, transmission)
  • Meningitis, Meningococcal (prevention & control, transmission)
  • Rifampin (therapeutic use)
  • Risk
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD